Using sodium bicarbonate to change 24-hour urine measurements in people with low urine citrate or uric acid kidney stones
Official title: Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers
Run by University of California, Irvine · NCT06335537 · Data updated 2026-11-12
This will see if taking sodium bicarbonate instead of potassium citrate changes 24-hour urine measurements in adults with low urine citrate or uric acid kidney stones.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of California, Irvine Academic / other |
| Locations | 1 site (Orange, California) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | July 2026 |
| Study ends | July 2026 |
| Registry record updated | June 24, 2025 |
| Trial ID | NCT06335537 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–79 who form calcium oxalate or uric acid stones, have low urine citrate (<320 mg/24 h), are currently taking Urocit-K, and do not have excluded conditions like reduced kidney function, diabetes, pregnancy, or certain GI/metabolic disorders.
✕Probably not a fit
Patients with impaired kidney function (eGFR <60), active diabetes, pregnancy or breastfeeding, those on thiazides or ACE inhibitors, or people whose stones are not related to low citrate or acidic urine are unlikely to benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 1 interventional study at the University of California, Irvine will switch eligible adults from potassium citrate (Urocit-K) to sodium bicarbonate and measure changes in 24-hour urine chemistry. Participants are adults with hypocitraturia (<320 mg/24 h) who form calcium oxalate or uric acid stones and are already on Urocit-K. The trial compares urinary citrate, urine pH, and other 24-hour urine parameters before and after the intervention. The protocol excludes people with reduced kidney function, diabetes, certain GI or metabolic disorders, pregnancy, or those taking thiazides or ACE inhibitors.
Why it matters
Potential benefit: If successful, sodium bicarbonate could offer a lower-cost alternative to potassium citrate to improve urine chemistry and lower stone recurrence risk.
How similar studies have gone: Potassium citrate is well established to raise urinary citrate, but substituting sodium bicarbonate as a lower-cost alternative has been less studied and remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> 18 years of age and \< 80 years of age, * Hypocitriuric (\<320 mg/24 hours), Calcium Oxalate Stone or Uric Acid stone formers, currently on Urocit-K therapy as the standard of care. Exclusion Criteria: * Male or female \<18 years old or \> 80 years old. * Currently taking thiazides or ACE inhibitor medications * Pregnant women. * Women who are breastfeeding or plan to breastfeed during study period * History of abnormal renal function (defined as eGFR \<60 mL/min/1.73 m2), active urinary tract infection, diabetes, cystinuria, renal tubular acidosis, inflammatory bowel disease, chronic diarrhea, primary hyperparathyroidism, peptic ulcer disease.
Where it's running
-
University of California, Irvine Medical Center
Orange, California, United States Recruiting
Study contacts
- Principal investigator: Sohrab N Ali, M.D — University of California, Irvine
- Study coordinator: Sohrab N Ali, M.D
- Email: sohrabna@hs.uci.edu
- Phone: 7145062352
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Lowering or stopping febuxostat in people with gout who have been well controlled for 5+ years
This test will see if reducing or briefly stopping febuxostat keeps uric acid low and prevents symptom return in people with gout who have had good control for at least five years.
-
Evaluating allopurinol's effect on cardiovascular events in high-risk patients
This study is testing if the medication allopurinol can help reduce heart problems in people aged 40-70 who have high uric acid levels and are at risk for cardiovascular issues.
-
Controlling blood uric acid after pancreatic cancer surgery to improve survival
This analysis will see if changes in blood uric acid after pancreatic cancer surgery relate to survival for people who had their tumor removed.
-
Understanding pediatric hypertension and its effects on the body
This study looks at how different factors related to blood pressure affect children aged 7-18 who have just been diagnosed with high blood pressure, to see how it impacts their health over two years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.